Thalassemia: Inherited Hemoglobin Deficiency Causing Anemia—Types, Symptoms, and Treatments

Thalassemias are autosomal recessive disorders of globin chain synthesis (α or β), leading to imbalanced globin production, ineffective erythropoiesis, and hemolytic anemia.

Types

  • α-thalassemia: Deletions/mutations in HBA1/HBA2 (chromosome 16). Severity correlates with number of affected alleles (1–4).
  • β-thalassemia: Mutations in HBB (chromosome 11). β⁰ (no β-globin) or β⁺ (reduced). Thalassemia major (transfusion-dependent), intermedia, minor (trait).

Epidemiology

High carrier frequency in Mediterranean, Middle Eastern, South/Southeast Asian, African descent (malaria protection).

Clinical Features

  • Anemia (microcytic, hypochromic)
  • Fatigue, pallor, growth failure
  • Extramedullary hematopoiesis (skeletal changes, hepatosplenomegaly)
  • Iron overload (transfusion + increased absorption)
  • Endocrine complications (diabetes, hypogonadism, hypothyroidism)

Management

  • Regular transfusions + iron chelation (deferasirox, deferiprone, deferoxamine) for major.
  • Folic acid supplementation.
  • Curative: Allogeneic HSCT (matched sibling best); gene therapy (betibeglogene autotemcel) approved for β-thalassemia.

With modern care, patients survive into adulthood with good quality of life.

Genetic Disorders - Related Articles